Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent IgA Nephropathy”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Looking for participantsNCT04663204
What this trial is testing

The Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

Who this might be right for
Immunoglobulin A NephropathyKidney DiseasesGlomerulonephritis, IGA+3 more
University of Leicester 24
Post-approval studies (Phase 4)UnknownNCT02571842
What this trial is testing

Rituximab in Recurrent IgA Nephropathy

Who this might be right for
Recurrent IgA Nephropathy
Chulalongkorn University 30
Post-approval studies (Phase 4)Ended earlyNCT02523768
What this trial is testing

Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

Who this might be right for
GlomerulonephritisIgAN
Centre Hospitalier Universitaire de Saint Etienne 117

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation